Keywords: arimidex, launched, early, breast, cancer, astrazeneca, its

Arimidex launched for early breast cancer

Article | 11 March 2002

Print This

AstraZeneca has launched its aromatase inhibitor Arimidex (anastrozole)in its first market, Japan, as a treatment for early breast cancer. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in